In the BioHarmony Drug Report Database

"Preview" Icon

Fostemsavir

Rukobia (fostemsavir) is a small molecule pharmaceutical. Fostemsavir was first approved as Rukobia on 2020-07-02. It is used to treat HIV infections in the USA. It has been approved in Europe to treat HIV infections. The pharmaceutical is active against Envelope surface glycoprotein gp160, precursor. Rukobia’s patent is valid until 2027-11-19 (FDA).

 

Trade Name

 

Rukobia
 

Common Name

 

fostemsavir
 

ChEMBL ID

 

CHEMBL3301594
 

Indication

 

hiv infections
 

Drug Class

 

Antivirals; phosphoro-derivatives

Image (chem structure or protein)

Fostemsavir structure rendering